Lupus and pregnancy: ten questions and some answers

1 Petri M Howard D Repke J . Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538 – 1545 .

2 Ruiz-Irastorza G Lima F Alves J . Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133 – 138 .

3 Urowitz MB Gladman DD Farewell VT Stewart J McDonald J . Lupus and pregnancy studies. Arthritis Rheum 1993; 36: 1392 – 1397 .

4 Clowse ME Magder L Witter F Petri M . Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006; 54: 3640 – 3647 .

5 Levy RA Vilela VS Cataldo MJ . Hydroxychloroquine in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001; 10: 401 – 404 .

6 Le Thi Huong D Wechsler B Vauthier-Brouzes D . Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997; 36: 772 – 777 .

7 Cortes-Hernandez J Ordi-Ros J Paredes F Casellas M Castillo F Vilardell-Tarres M . Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 643 – 650 .

8 Khamashta MA Ruiz-Irastorza G Hughes GRV . Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997; 23: 15 – 30 .

9 Petri M . The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin N Am 2007; 33: 27 – 35 .

10 Buyon JP Kalunian KC Ramsey-Goldman R . Assessing disease activity in SLE patients during pregnancy. Lupus 1999; 8: 677 – 684 .

11 Ruiz-Irastorza G Khamashta MA Gordon C . Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum 2004; 51: 78 – 82 .

12 Opatrny L David M Kahn SR . Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33: 2214 – 2221 .

13 Clowse MEB Magder LS Petri M . The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52: 514 – 521 .

14 Georgiou PE Politi EN Katsimbri P Sakka V Drosos AA . Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 2000; 39: 1014 – 1019 .

15 Germain S Nelson-Piercy C . Lupus nephritis and renal disease in pregnancy. Lupus 2006; 15: 148 – 155 .

16 Lima F Khamashta MA Buchanan NMM Kerslake S Hunt BJ Hughes GRV . A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131 – 136 .

17 Ramsey-Goldman R Kutzer JE Kuller LH Guzick D Carpenter AB Medsger TA . Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 1993; 138; 1057 – 1069 .

18 Branch DW Khamashta MA . Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 2003; 101: 1333 – 1344 .

19 Brucato A Frassi M Franceschini F . Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832 – 1835 .

20 Izmirly PM Rivera TL Buyon JP . Neonatal lupus syndromes. Rheum Dis Clin N Am 2007; 33: 267 – 285 .

21 Cuadrado MJ Mendonça LLF Khamashta MA . Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 1999; 42: S265 .

22 Ruiz-Irastorza G Khamashta MA Hughes GRV . Heart disease, pregnancy and systemic autoimmune diseases. In: Oakley, C, Warnes, CA, (eds), Heart disease in pregnancy, second edition. Blackwell publishing; 2007. p. 136–150. Oxford, UK.

23 Bonnin M Mercier FJ Sitbon O . Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133 – 1137 .

24 McMillan E Martin WL Waugh J . Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 2002; 11: 392 – 398 .

25 Mackillop LH Germain SJ Nelson-Piercy C . Systemic lupus erythematosus. Br Med J 2007; 335: 933 – 936 .

26 Ruiz-Irastorza G Khamashta MA Nelson-Piercy C Hughes GRV . Effects of lupus and antiphospholipid syndrome on pregnancy. Yearb Obstet Gynaecol 2002; 10: 105 – 119 .

27 Ostensen M Khamashta M Lockshin M . Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8: 209 – 227 .

28 Milne F Redman C Walker J . The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J 2005; 330: 576 – 580 .

29 Clowse M . Lupus activity in pregnancy. Rheum Dis Clin N Am 2007; 33: 237 – 252 .

30 Askie LM Duley L Henderson-Smart DJ Stewart LA . on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791 – 1980 .

31 Papageorghiou AT Roberts N . Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 2005; 17: 584 – 590 .

32 Le Thi Huong D Wechsler B Vauthier-Brouzes D . The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 2006; 45: 332 – 338 .

33 Carmona F Font J Cervera R Muñoz F Cararach V Balasch J . Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999; 83: 137 – 142 .

34 Ruiz-Irastorza G Khamashta MA Hughes GRV . Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 2002; 1: 298 – 304 .

35 Ruiz-Irastorza G Khamashta MA . Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 2005; 1051: 606 – 612 .

36 Wetzl RG . Anesthesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 2004; 13: 699 – 702 .

37 Horlocker TT Wedel DJ Benzon H . Regional anesthesia in the anticoagulated patient: defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and anticoagulation). Reg Anesth Pain Med 2003; 28: 172 – 197 .

38 Le Thi Huong D Wechsler B Vauthier-Brouzes D . Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 2002; 32: 174 - 188 .

39 Guballa N Sammaritano L Schwartzman S Buyon J Lockshin MD . Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43: 550 – 556 .

40 Lockshin MD . Autoimmunity, infertility and assisted reproductive technologies. Lupus. 2004; 13: 669 – 672 .

41 Ruiz-Irastorza G Khamashta MA Nelson-Piercy C Hughes GRV . Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 2001; 10: 597 – 600 .